Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting ...

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.



from Content Keyword RSS http://ift.tt/1uYC0wB

via IFTTT